blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1904442

EP1904442 - HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.07.2012
Database last updated on 15.06.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis, IN 46285 / US
[N/P]
Former [2008/14]For all designated states
ELI LILLY AND COMPANY
Lilly Corporate Center
Indianapolis IN 46285 / US
Inventor(s)01 / BEAVERS, Lisa, Selsam
74 North Edwards Street
Franklin, Indiana 46131 / US
02 / FINLEY, Don, Richard
4644 Macy Drive
Greenwood, Indiana 46142 / US
03 / GADSKI, Robert, Alan
4431 North Illinois
Indianapolis, Indiana 46208 / US
04 / HIPSKIND, Philip, Arthur
4255 Cabin Court
New Palestine, Indiana 46163 / US
05 / HORNBACK, William, Joseph
10063 Bent Tree Lane
Fishers, Indiana 46037 / US
06 / JESUDASON, Cynthia, Darshini
1090 Fleetwood Drive
Indianapolis, Indiana 46228 / US
07 / PICKARD, Richard, Todd
20980 Prairie Baptist Road
Noblesville, Indiana 46060 / US
08 / TAKAKUWA, Takako
7653 Germander Lane
Indianapolis, Indiana 46237 / US
09 / VAUGHT, Grant, Mathews
7255 Lakeland Trails Blvd.
Indianapolis, Indiana 46259 / US
 [2008/19]
Former [2008/14]01 / BEAVERS, Lisa, Selsam
74 North Edwards Street
Franklin, Indiana 46131 / US
02 / FINLEY, Don, Richard
4644 Macy Drive
Greenwood, Indiana 46142 / US
03 / GADSKI, Robert, Alan
4431 North Illinois
Indianapolis, Indiana 46208 / US
04 / HIPSKIND, Philip, Arthur
4255 Cabin Court
New Palestine, Indiana 46163 / US
05 / HORNBACK, William, Joseph
10063 Bent Tree Lane
Fishers, Indiana 46037 / US
06 / JESUDASON, Cynthia, Darshini
1090 Fleetwood Drive
Indianapolis, Indiana 46228 / US
07 / PICKARD, Richard, Todd
20980 Prairie Baptist Road
Noblesville, Indiana 46060 / US
08 / TAKAKUWA, Takako
7653 Germander Lane
Indianapolis, Indiana 46237 / US
09 / VAUGHT, Grant, Mathews
7352 Tarragon Lane
Indianapolis, Indiana 46237 / US
Representative(s)Suarez-Miles, Ana Sanchiz, et al
Eli Lilly and Company Limited
European Patent Operations
Lilly Research Centre, Erl Wood Manor
Sunninghill Road
Windlesham, Surrey GU20 6PH / GB
[N/P]
Former [2008/14]Suarez-Miles, Ana Sanchiz, et al
Eli Lilly and Company Limited European Patent Operations Lilly Research Centre, Erl Wood Manor Sunninghill Road
Windlesham, Surrey GU20 6PH / GB
Application number, filing date06774260.128.06.2006
[2008/14]
WO2006US25328
Priority number, dateUS20050696257P01.07.2005         Original published format: US 696257 P
[2008/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007005503
Date:11.01.2007
Language:EN
[2007/02]
Type: A1 Application with search report 
No.:EP1904442
Date:02.04.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 11.01.2007 takes the place of the publication of the European patent application.
[2008/14]
Type: B1 Patent specification 
No.:EP1904442
Date:07.09.2011
Language:EN
[2011/36]
Search report(s)International search report - published on:EP11.01.2007
ClassificationIPC:C07D207/09, C07D403/12, C07D401/12, A61K31/4025, A61P3/04, A61P25/28
[2008/14]
CPC:
C07D207/09 (EP,US); A61P25/00 (EP); A61P25/28 (EP);
A61P3/04 (EP); C07D401/12 (EP,US); C07D403/12 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/14]
TitleGerman:HISTAMIN-H3-REZEPTOR-MITTEL, DEREN HERSTELLUNG UND THERAPEUTISCHE VERWENDUNG[2008/14]
English:HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES[2008/14]
French:AGENTS RECEPTEURS DE L'HISTAMINE H3, PREPARATION ET UTILISATIONS THERAPEUTIQUES[2008/14]
Entry into regional phase01.02.2008National basic fee paid 
01.02.2008Designation fee(s) paid 
01.02.2008Examination fee paid 
Examination procedure06.12.2007Amendment by applicant (claims and/or description)
01.02.2008Examination requested  [2008/14]
28.01.2009Despatch of a communication from the examining division (Time limit: M06)
21.07.2009Reply to a communication from the examining division
21.07.2010Despatch of a communication from the examining division (Time limit: M04)
09.11.2010Reply to a communication from the examining division
14.04.2011Communication of intention to grant the patent
18.07.2011Fee for grant paid
18.07.2011Fee for publishing/printing paid
Divisional application(s)EP11151531.8  / EP2322506
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.01.2009
Opposition(s)11.06.2012No opposition filed within time limit [2012/33]
Fees paidRenewal fee
30.06.2008Renewal fee patent year 03
30.06.2009Renewal fee patent year 04
30.06.2010Renewal fee patent year 05
30.06.2011Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.06.2006
AT07.09.2011
BE07.09.2011
CY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
LT07.09.2011
LV07.09.2011
NL07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
TR07.09.2011
BG07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
[2014/34]
Former [2014/21]AT07.09.2011
BE07.09.2011
CY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
LT07.09.2011
LV07.09.2011
NL07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
TR07.09.2011
BG07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2013/29]AT07.09.2011
BE07.09.2011
CY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
LT07.09.2011
LV07.09.2011
NL07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
BG07.12.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2012/35]AT07.09.2011
BE07.09.2011
CY07.09.2011
CZ07.09.2011
DK07.09.2011
EE07.09.2011
FI07.09.2011
LT07.09.2011
LV07.09.2011
NL07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2012/26]AT07.09.2011
BE07.09.2011
CY07.09.2011
CZ07.09.2011
EE07.09.2011
FI07.09.2011
LT07.09.2011
LV07.09.2011
NL07.09.2011
PL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2012/23]AT07.09.2011
BE07.09.2011
CY07.09.2011
CZ07.09.2011
EE07.09.2011
FI07.09.2011
LT07.09.2011
LV07.09.2011
NL07.09.2011
RO07.09.2011
SE07.09.2011
SI07.09.2011
SK07.09.2011
GR08.12.2011
IS07.01.2012
PT09.01.2012
Former [2012/21]AT07.09.2011
BE07.09.2011
CY07.09.2011
CZ07.09.2011
FI07.09.2011
LT07.09.2011
LV07.09.2011
SE07.09.2011
SI07.09.2011
GR08.12.2011
IS07.01.2012
Former [2012/18]AT07.09.2011
BE07.09.2011
CY07.09.2011
FI07.09.2011
LT07.09.2011
LV07.09.2011
SE07.09.2011
SI07.09.2011
GR08.12.2011
Former [2012/12]AT07.09.2011
CY07.09.2011
FI07.09.2011
LT07.09.2011
LV07.09.2011
SE07.09.2011
SI07.09.2011
GR08.12.2011
Former [2012/11]AT07.09.2011
FI07.09.2011
LT07.09.2011
LV07.09.2011
SE07.09.2011
SI07.09.2011
GR08.12.2011
Former [2012/10]FI07.09.2011
LT07.09.2011
SE07.09.2011
GR08.12.2011
Former [2012/09]FI07.09.2011
LT07.09.2011
Former [2012/08]LT07.09.2011
Cited inInternational search[Y]WO02076925  (LILLY CO ELI [US], et al) [Y] 1-17 * claim - * * claim 7; compounds 130-133,136,144,209-216,229-235,261,262,269,270,28; sequences 1,288,289,295,318-324 *;
 [Y]WO03064411  (NOVO NORDISK AS [DK], et al) [Y] 1-17 * claim - ** example 17 *;
 [Y]WO2004037257  (JANSSEN PHARMACEUTICA NV [BE], et al) [Y] 1-17 * claim - * * definition of R4 *;
 [PY]WO2006011042  (PFIZER PROD INC [US], et al) [PY] 1-17 * claim - *
by applicantEP0838448
 WO02076925
    - ODA T. ET AL., J.BIOL.CHEM., vol. 275, no. 47
    - KLAUSNER; BODANSKY, SYNTHESIS, (1972), vol. 9, pages 453 - 463
    - S.M. BERGE ET AL., "Pharmaceutical Salts", JOURNAL OF PHARMACEUTICAL SCIENCES, (197701), vol. 66, no. 1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.